Sunday, January 27, 2013

Generic Drug User Fee Act (GDUFA) - What will be the implications for the consumer & for the generic API manufacturers based outside NA & EU

›
20 August, 2011 Posted in Linkedin Answers by Murali Apparaju For those who remember SOCMA & EFCG making a fervent pitch in 2...
Saturday, January 26, 2013

NRAchists in gun-afflicted america....

›
December 2012 My comment on a LinkedIn article on need for Gun Control in USA, I only see the comments now, no article!!, still an int...
1 comment:

Caste, gender & slur - Quite an explosive cocktail!! :-)

›
01 March 2009 Wow, this repro' is a dinosaur, way back from 2009!!! - my comment below was on a real flamer of a topic that was origi...
Friday, January 25, 2013

3200% premium for innovation!!

›
April 2012 Discussion posted on Pharmaceutical Discussion Group on Linkedin http://www.linkedin.com/groups/PhRMA-says-price-as-trig...

Why won't Gates spend a few more cents (per dose) on non-mercury biocides & shut-up the vaccine detractors?

›
April 2012 Discussion posted on Pharmaceutical Discussion Group on LI - by Murali Apparaju http://www.linkedin.com/groups/Why-wont-G...
1 comment:
Thursday, January 24, 2013

Review of Mahendra Ramsinghani's "The Business of Venture Capital: Insights from Leading Practitioners on the Art of Raising a Fund, Deal Structuring, Value Creation, and Exit Strategies

›
21 Aug 2012 Review Posted on Amazon.com http://www.amazon.com/review/R2Q6WI836ZOCJT/ref=cm_cr_pr_perm?ie=UTF8&ASIN=0470874449&li...

The clinical attrition of INX-189 post a 2.5 billion acquisition - are investors into life sciences really looking at where the buck is headed?

›
October 2012 Discussion initiated on Global Private Equity & Venture Capital  group on Linkedin http://www.linkedin.com/groupItem?vi...
1 comment: